SCHEMBL2712690

SCHEMBL2712690

O=C(Nc1ncco1)c1ccncc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.55
NAMPT P43490 1/20 0.53
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 2/20 0.50
HTT P42858 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
PSMD14 O00487 1/20 0.50
STAMBP O95630 1/20 0.50
COPS5 Q92905 1/20 0.50
KMT2A Q03164 1/20 0.48
MAPK1 P28482 2/20 0.47
MPO P05164 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2A6 P11509 1/20 0.47
CYP2C19 P33261 1/20 0.47
CSNK2A2 P19784 1/20 0.47
CSNK2B P67870 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8124745 0.86 NAMPT (0.60) NAMPTKDM4EALDH1A1HTTL3MBTL1
SCHEMBL28232648 0.81 LMNA (0.58) NAMPTKDM4EHTTL3MBTL1PSMD14
SCHEMBL3647333 0.75 PSMD14 (0.53) NAMPTKDM4EHTTL3MBTL1PSMD14
SCHEMBL6330501 0.75 NAMPT (0.50) GAANAMPTKDM4EALDH1A1HTT
SCHEMBL3893088 0.74 PSMD14 (0.46) NAMPTPSMD14STAMBPCOPS5KMT2A
SCHEMBL3070030 0.74
SCHEMBL28469134 0.73 NPC1 (0.55) GAAKDM4EALDH1A1L3MBTL1KMT2A
SCHEMBL24163103 0.72 EPHX2 (0.52) NAMPTHTTL3MBTL1PSMD14STAMBP
SCHEMBL24163879 0.72 KMO (0.60) NAMPTKDM4EALDH1A1PSMD14STAMBP
SCHEMBL18132565 0.72 KMT2A (0.56) NAMPTKDM4EALDH1A1HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453789-A2 N,N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES Elan Pharmaceuticals, Inc. (US) 2004-09-08 EP claimed
WO-2003040096-A2 N, N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES ELAN PHARMACEUTICALS, INC. (US) 2003-05-15 WO claimed
WO-2012054510-A1 OXADIAZOLE COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF COMENTIS, INC. (US) 2012-04-26 WO disclosed